Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Parie Garg

Partner, Health & Life Sciences, Oliver Wyman

The cost and toll of the opioid epidemic on the Medicaid population is alarming. Learn what states are doing to help address the problem.

Partner, Health & Life Sciences, Oliver Wyman
Global Head, Health Services, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

For health systems to improve access, success requires a mix of analytical and operational capabilities across the care continuum.

Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Now more than ever, Medicaid MCOs need the right providers in their network.

Partner, Health & Life Sciences, Oliver Wyman
Associate, Health & Life Sciences, Oliver Wyman

While the healthcare consumer is increasingly seeking price information prior to seeking care, the industry lags behind in the provision of that information.

Partner, Health & Life Sciences, Oliver Wyman

The demand for managed long-term services and support is up, and expected to climb higher. What payers need to know about managing this complex line of business.

Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Two scenarios for how repeal and replace changes might unfold.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Six reasons why Medicaid MCOs are killing it on the exchange.

Partner, Health & Life Sciences, Oliver Wyman

Efforts that companies are making to provide more effective health information for vulnerable individuals within their employee populations.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Leaders of financial investment firms share their views on funding companies that provide health information to vulnerable populations.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

A perspective on how pediatric healthcare providers are changing their financial and care models in the evolving value-based market to lower costs and improve outcomes in children’s health.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Trion/MMA

Insights in your inbox

Subscribe